Shares of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX – Get Rating) have been given an average rating of “Moderate Buy” by the eight analysts that are currently covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12 month price target among brokers that have issued a report on the stock in the last year is $21.40.
Several equities research analysts have weighed in on MDRX shares. Piper Sandler lowered their price objective on shares of Allscripts Healthcare Solutions from $19.00 to $17.00 in a research report on Thursday, June 9th. StockNews.com lowered Allscripts Healthcare Solutions from a “buy” rating to a “hold” rating in a research report on Friday, May 13th. Finally, TheStreet downgraded Allscripts Healthcare Solutions from a “b” rating to a “c” rating in a research report on Friday, May 6th.
In related news, insider Thomas Langan sold 51,537 shares of the stock in a transaction that occurred on Tuesday, May 10th. The shares were sold at an average price of $18.12, for a total value of $933,850.44. Following the sale, the insider now directly owns 139,912 shares in the company, valued at approximately $2,535,205.44. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Paul Black sold 60,000 shares of Allscripts Healthcare Solutions stock in a transaction that occurred on Friday, June 10th. The stock was sold at an average price of $16.58, for a total transaction of $994,800.00. Following the transaction, the director now directly owns 1,254,631 shares in the company, valued at approximately $20,801,781.98. The disclosure for this sale can be found here. Insiders have sold a total of 318,015 shares of company stock valued at $5,550,054 in the last ninety days. Company insiders own 2.29% of the company’s stock.
Institutional investors and hedge funds have recently bought and sold shares of the business. State of Alaska Department of Revenue grew its holdings in shares of Allscripts Healthcare Solutions by 2.6% in the 2nd quarter. State of Alaska Department of Revenue now owns 87,711 shares of the software maker’s stock valued at $1,300,000 after buying an additional 2,205 shares during the period. Alyeska Investment Group L.P. bought a new position in Allscripts Healthcare Solutions during the first quarter worth about $11,823,000. Polar Capital Holdings Plc acquired a new position in Allscripts Healthcare Solutions in the first quarter valued at about $250,000. Royal Bank of Canada increased its holdings in shares of Allscripts Healthcare Solutions by 9.5% in the first quarter. Royal Bank of Canada now owns 1,316,473 shares of the software maker’s stock worth $29,647,000 after acquiring an additional 113,940 shares in the last quarter. Finally, Eqis Capital Management Inc. acquired a new stake in shares of Allscripts Healthcare Solutions during the first quarter worth about $240,000.
Shares of Allscripts Healthcare Solutions stock opened at $14.67 on Friday. The stock has a market capitalization of $1.70 billion, a price-to-earnings ratio of 13.10, a P/E/G ratio of 1.34 and a beta of 1.03. The firm’s 50-day moving average price is $16.74 and its two-hundred day moving average price is $19.21. The company has a current ratio of 2.38, a quick ratio of 2.38 and a debt-to-equity ratio of 0.28. Allscripts Healthcare Solutions has a 1-year low of $13.05 and a 1-year high of $23.25.
Allscripts Healthcare Solutions (NASDAQ:MDRX – Get Rating) last released its quarterly earnings results on Thursday, May 5th. The software maker reported $0.09 EPS for the quarter, missing analysts’ consensus estimates of $0.13 by ($0.04). Allscripts Healthcare Solutions had a return on equity of 10.97% and a net margin of 11.60%. The business had revenue of $142.70 million for the quarter, compared to the consensus estimate of $139.67 million. During the same quarter last year, the company earned $0.13 earnings per share. The firm’s revenue was up 6.7% on a year-over-year basis. As a group, equities research analysts predict that Allscripts Healthcare Solutions will post 0.67 EPS for the current year.
About Allscripts Healthcare Solutions (Get Rating)
Allscripts Healthcare Solutions, Inc, together with its subsidiaries, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Receive News & Ratings for Allscripts Healthcare Solutions Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com’s FREE daily email newsletter.